glp 1 agonist compounding pharmacy Webster GLP-1 Compounding: When Innovation May

An imbalance in the gut microbial community can trigger inflammatory responses and modulate GLP-1 secretion, while GLP-1 itself may influence both immune signaling and microbial composition

BMJ 2010

GLP-1RAs have been shown to greatly reduce the body weight of obese people with type 2 diabetes.814 The US Food and Drug Administration has approved several different formulations or doses of GLP-1RAs for the treatment of type 2 diabetes: exenatide, liraglutide, dulaglutide, albiglutide, lixisenatide, semaglutide, and tirzepatide.15 Given the wide variety of GLP-1RA drugs, the differences in pharmacokinetics, efficacy, adverse reaction rates, and dosing requirements of each GLP-1RA need to be evaluated independently.16 Additionally, clinicians need to understand the advantages and disadvantages of each GLP-1RA drug to reach the appropriate clinical decisions

To enhance screening efficiency, duplicates were removed using EndNote 20

Each of these medications has its unique properties and dosing schedules

(2) RCTs completed before the FDA guidance of 2008 [17] and (3) follow-up duration of at least 6 months